Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Intravenous (IV) Ibuprofen Market?

The market size for intravenous (iv) ibuprofen has seen a swift expansion in past years. It is forecasted to escalate from $8.35 billion in 2024 to $9.37 billion in 2025, registering a compound annual growth rate (CAGR) of 12.3%. The upward trend during the historical period is due to the rising incidence of persistent illnesses, an increase in surgical operations, a growing focus on reducing opioid consumption, an elevation in per capita income, and the expansion of medical tourism.

In the coming years, the market for intravenous (iv) ibuprofen is predicted to experience fast-paced growth. The market is projected to reach a value of $14.72 billion in 2029, growing at a compound annual growth rate (CAGR) of 11.9%. Steady growth in the forecast period can be accredited to a surge in healthcare investments, growth in the number of pediatric patients, a higher incidence of pain and fever, an increase in the elderly population and the heightened utilization of advanced therapeutic options. Prominent trends for the forecast period incorporate state-of-the-art therapeutic solutions, single-dose formulas, advancements in individualized medicine, the adaptation into multimodal pain management procedures and forward strides in combined therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23429&type=smp

What Market Forces Are Contributing To The Growth Of The Intravenous (IV) Ibuprofen Market?

The expected growth of the intravenous ibuprofen market is linked to the increasing occurrence of pain disorders. Such disorders, marked by persistent or chronic pain impacting day-to-day activities, are often due to nerve, musculoskeletal, or inflammatory problems. Ageing populations contribute to the increased occurrence of pain disorders as elderly individuals are more susceptible to developing chronic ailments such as arthritis, osteoarthritis, and nerve pain, thereby amplifying the demand for efficient pain relief methods. Intravenous ibuprofen caters to this need by offering rapid pain alleviation, making it perfectly suited for handling acute and post-surgical pain. This treatment minimises inflammation and boosts patient comfort, thereby enhancing the efficacy of medical care. As an example, data from the UK’s Office for Health Improvement and Disparities in January 2024 indicates that the proportion of individuals aged 16 and older self-reporting long-term musculoskeletal conditions increased to 18.4% in 2023, a rise from 17.6% in 2022. As a result, the expanding incidence of pain disorders fuels the growth of the intravenous ibuprofen market.

Which Segmentation Factors Are Critical In The Intravenous (IV) Ibuprofen Market Analysis?

The intravenous (iv) ibuprofenmarket covered in this report is segmented –

1) By Product Type: Conventional Intravenous (IV) Ibuprofen; High-Concentration Intravenous (IV) Ibuprofen

2) By Strength: 100 Milligrams (mg); 200 Milligrams (mg); 400 Milligrams (mg); 800 Milligrams (mg)

3) By Age Group: Pediatrics; Adults

4) By Application: Pain; Fever; Inflammation; Other Applications

5) By End-User: Hospitals; Ambulatory Surgical Centers; Clinics; Other End-Users

Subsegments:

1) By Conventional Intravenous (IV) Ibuprofen: Pediatric Intravenous (IV) Ibuprofen; Adult Intravenous (IV) Ibuprofen

2) By High-Concentration Intravenous (IV) Ibuprofen: Single-Dose Vial; Multi-Dose Vial

What New Opportunities Are Emerging From Trends In The Intravenous (IV) Ibuprofen Market?

Leading corporations in the intravenous ibuprofen marketplace are emphasizing the creation of innovative drug recipes, such as non-opioid pain relievers to improve pain control while reducing opioid dependence. A non-opioid analgesic is a painkiller that doesn’t rely on opioids and is free from the addiction and side effects associated with opioids. For example, Hikma Pharmaceuticals plc, a pharmaceutical firm based in the UK, introduced COMBOGESIC IV (acetaminophen and ibuprofen) via injection to the US market in February 2024, after the Food and Drug Administration (FDA) gave its approval in October 2023. This injectable, non-opioid painkiller is suited for mild to moderate pain relief and can be used as an additional treatment for severe pain control. By blending two active components with unique mechanisms, COMBOGESIC IV offers a fresh, non-opioid solution for pain management for medical professionals.

Which Organizations Are At The Forefront Of The Intravenous (IV) Ibuprofen Market?

Major companies operating in the intravenous (IV) ibuprofen market are Pfizer Inc., Sanofi S.A., Novartis AG, Fresenius SE & Co. KGaA, Teva Pharmaceutical Industries Ltd., Baxter International, Mylan N.V., Sandoz Group AG, Grifols S.A., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, CSL Limited, Eurolife Healthcare Pvt. Ltd., B. Braun Holding GmbH & Co. KG, AFT Pharmaceuticals Ltd, Cumberland Pharmaceuticals Inc., Delex Pharma International Inc., Recordati Rare Diseases Inc., Xgen Pharmaceuticals Djb Inc., Wellona Pharma, Hyloris Pharmaceuticals SA

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/intravenous-iv-ibuprofen-global-market-report

Which Region Is Leading Innovation In The Intravenous (IV) Ibuprofen Market?

North America was the largest region in the intravenous (IV) ibuprofen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (IV) ibuprofen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23429&type=smp

Browse Through More Reports Similar to the Global Intravenous (IV) Ibuprofen Market 2025, By The Business Research Company

Intravenous Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Intravenous Immunoglobulin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

Intravenous Iv Hydration Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-iv-hydration-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model